SenzaGen is present at the Medical Design & Manufacturing (MD&M) Minneapolis The MD&M Minneapolis Conference is the region's largest educational offering of its kind, taking place in North America's second largest hub for medical device innovation — the Midwest. This year's conference lineup features a curated roster of speakers with deeply technical expertise in everything from product […]
SenzaGen is participating at The American College of Toxicology 2018 Annual Meeting that will be held Nov. 4-7 in West Palm Beach. This year’s meeting will feature lectures, poster sessions, and other events for today’s toxicologists to network with each other and hone their skills. For more information on ACT 2018, please visit www.actox.org.
24th annual conference
SenzaGen is participating at the Biocompatibility for Medical Devices, Barcelona. Updates and changes to the ISO 10993 standards, regulatory updates and case studies of how to use ISO 10993 for evaluation of Medical Devices ISO 10993: ARE YOU BIOCOMPATIBLE? Risk Mitigation. Chemical Characterisation. Practical Implementation. Meet our Medical Device experts Rose-Marie Jenvert and Joshua Schmidt […]
En 2018, le congrès annuel de la SFT a lieu à Lille, les 27 et 28 novembre, espace Jeanne de Flandre (Lille Grand Palais). Poster GARD® – in vitro safety assessment of skin and respiratory sensitizers using a genomics-based platform Meet Anna Cherouvrier Hansson at the conference. To book a meeting, please email: anna.c.hansson (at) […]
Dr Andy Forreryd is one of three speakers at the Human Safety Seminar organised by Eurofins BioPharma Product Testing Munich where he is to present the GARD platform for skin and respiratory sensitization Topics for the seminar: In vitro Methods to test for Endocrine Disrupting Properties In vitro Skin sensitization – Challenges to Overcome Eye Irritation ex vivo and in vitro methods – Current status GARD […]
In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform A seminar given on two occasions, this one targeted for the EUROPEAN time zone The presentation will give insight into the latest in vitro technology for identifying respiratory sensitizers using human dendritic-like cell lines and genomics. A thorough explanation of the […]
In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform A seminar given on two occasion. This one targeted forthe US audience at 13:00 EST (19:00 CET) The presentation will give insight into the latest in vitro technology for identifying respiratory sensitizers using human dendritic-like cell lines and genomics. […]
SenzaGen is participating at The Society of Toxicology of Canada 50th Annual Symposium, Winter 2018 WHAT’S IN A NAM ? (NOVEL APPROACH METHODOLOGIES). BENEFITS, LIMITATIONS, TRANSLATION, COMMUNICATION. | DECEMBER 10 TO 12, 2018 | | VENUE: COURTYARD BY MARRIOTT - TORONTO | The Society of Toxicology of Canada Inc. is a non-profit association whose objectives […]
SenzaGen is attending the Training and Knowledge-sharing Workshop - "Applying non-animal strategies for assessing skin sensitization" in Helsinki, Finland. The main objective of the workshop is to discuss how the information produced from non-animal assays for skin sensitisation can be used in regulatory decision-making for hazard identification (classification & labelling) but also for risk assessment decisions, […]
